<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Fetuin-A is a <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> that inhibits extraosseous and <z:hpo ids='HP_0004934'>vascular calcification</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Its serum level is lower in patients with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> compared with healthy controls, but its role is unknown in aneurysmal diseases </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of our study was to investigate the association of serum fetuin-A levels with <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> of different aetiology: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: In a single centre cross-sectional observational study, 105 patients (30 with atherosclerotic <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo>, 15 with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, 30 with <z:hpo ids='HP_0004950'>peripheral arterial disease</z:hpo> and 30 healthy controls) were examined; sera were analysed for fetuin-A, standard markers of possible <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, kidney and <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">hepatic disease</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Systemic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> was assessed by carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) measurement and <z:hpo ids='HP_0003207'>arterial calcification</z:hpo> score of cardiac valves, carotids, aorta and femoral arteries determined by ultrasound </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Serum fetuin-A levels (median and IQR) were significantly lower in the atherosclerotic <z:hpo ids='HP_0002617'>aneurysm</z:hpo> cohort than in patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>: 708 μg mL⁻¹ (612-780) and 756 μg mL⁻¹ (708-816), respectively, (P = 0·0428) </plain></SENT>
<SENT sid="6" pm="."><plain>Fetuin-A levels were 754 μg mL⁻¹ (713-777) in the control group and 654 μg mL⁻¹ (600-756) in patients with <z:hpo ids='HP_0004950'>peripheral arterial disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Mean and maximum <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, ACS values and <z:chebi fb="0" ids="17230">homocysteine</z:chebi> levels were significantly higher in patients with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>: P &lt; 0·0001, P &lt; 0·0001, P &lt; 0·0001 and P = 0·0034, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>There was no significant difference between <z:hpo ids='HP_0002617'>aneurysm</z:hpo> groups analysing the results of <z:chebi fb="23" ids="18059">lipid</z:chebi> profile and <z:hpo ids='HP_0011009'>acute</z:hpo>-phase markers </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The significantly lower serum level of fetuin-A in the atherosclerotic <z:hpo ids='HP_0002617'>aneurysm</z:hpo> group supports the protective role of fetuin-A in the evolution of <z:hpo ids='HP_0003207'>arterial calcification</z:hpo> </plain></SENT>
</text></document>